These results show that MSH6 is the most important MMR gene in endometrial cancer that may be related to Lynch syndrome and that the Amsterdam Criteria II identify only about half of the cases with germ cell mutation of MMR genes. This evidence concerns the gene MSH6 and Lynch syndrome.